{"id":"technetium-tc99m-sestamibi","safety":{"commonSideEffects":[{"rate":null,"effect":"Headache"},{"rate":null,"effect":"Dizziness"},{"rate":null,"effect":"Chest discomfort (exercise-induced)"},{"rate":"rare","effect":"Hypersensitivity reactions"}]},"_chembl":null,"_dailymed":{"setId":"8626e756-767a-4a14-9188-658b58185254","title":"KIT FOR THE PREPARATION OF TECHNETIUM TC99M SESTAMIBI INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [CARDINAL HEALTH 414, LLC]"},"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"The drug is a lipophilic cationic complex that crosses cell membranes and localizes in mitochondria based on the negative membrane potential of viable cells. It is used as a tracer in single-photon emission computed tomography (SPECT) imaging to assess regional myocardial blood flow, detect ischemia, and evaluate cardiac viability. The degree of uptake correlates with myocardial perfusion and cellular viability.","oneSentence":"Technetium Tc-99m sestamibi is a radiopharmaceutical that accumulates in mitochondria of viable myocardial cells, allowing visualization of myocardial perfusion and viability via nuclear imaging.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:11:29.299Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Myocardial perfusion imaging to assess coronary artery disease and ischemia"},{"name":"Evaluation of myocardial viability in patients with coronary artery disease"},{"name":"Risk stratification in patients with known or suspected coronary artery disease"}]},"trialDetails":[{"nctId":"NCT03996850","phase":"","title":"SPECT/CT for the Characterization of Renal Masses","status":"ACTIVE_NOT_RECRUITING","sponsor":"Jonsson Comprehensive Cancer Center","startDate":"2018-12-07","conditions":"Kidney Neoplasm, Renal Mass","enrollment":102},{"nctId":"NCT02324387","phase":"NA","title":"Tc99m Sestamibi Molecular Breast Imaging","status":"ACTIVE_NOT_RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2015-06-15","conditions":"Breast Cancer","enrollment":96},{"nctId":"NCT05042687","phase":"NA","title":"Comparative Performance of Molecular Breast Imaging (MBI) to Magnetic Resonance Imaging (MRI) of the Breast in Identifying and Excluding Breast Carcinoma in Women at High Risk for Breast Cancer","status":"RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2021-12-13","conditions":"Breast Cancer","enrollment":300},{"nctId":"NCT02744053","phase":"EARLY_PHASE1","title":"DCE-MRI and MBI in Assessing Tumor Response to Chemotherapy in Patients With Triple Negative Breast Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2016-11-07","conditions":"Estrogen Receptor Negative, HER2/Neu Negative, Progesterone Receptor Negative","enrollment":96},{"nctId":"NCT06058650","phase":"NA","title":"Molecular Breast Imaging Guidance for Breast Biopsy for Patients With Breast Abnormalities","status":"RECRUITING","sponsor":"Mayo Clinic","startDate":"2021-08-26","conditions":"Breast Neoplasm","enrollment":70},{"nctId":"NCT01334918","phase":"PHASE2","title":"A Study of Regadenoson in Subjects Undergoing Stress Myocardial Perfusion Imaging (MPI) Using Multidetector Computed Tomography (MDCT) Compared to Single Photon Emission Computed Tomography (SPECT)","status":"COMPLETED","sponsor":"Astellas Pharma Inc","startDate":"2011-04-26","conditions":"Coronary Artery Disease (CAD)","enrollment":124},{"nctId":"NCT00826280","phase":"PHASE3","title":"Caffeine's Effect on Regadenoson Administration With Single Photon Emission Computed Tomography (SPECT) Myocardial Perfusion Imaging (MPI)","status":"COMPLETED","sponsor":"Astellas Pharma Inc","startDate":"2009-03-24","conditions":"Coronary Artery Disease (CAD)","enrollment":347},{"nctId":"NCT04316845","phase":"NA","title":"18F-fluorocholine PET/CT for Hyperparathyroidism","status":"COMPLETED","sponsor":"Buddhist Tzu Chi General Hospital","startDate":"2018-01-16","conditions":"Hyperparathyroidism","enrollment":38},{"nctId":"NCT04040946","phase":"PHASE3","title":"Trial Comparing 2 Diagnostic Strategies for Preoperative Localization of Parathyroid Adenoma in Primary Hyperparathyroidism:TEMP / CT With Tc99m-sestaMIBI or PET / CT With F18-choline in First Intention","status":"COMPLETED","sponsor":"Centre Francois Baclesse","startDate":"2019-09-19","conditions":"Parathyroid Adenoma, Hyperparathyroidism, F18-choline","enrollment":59},{"nctId":"NCT00560495","phase":"PHASE1","title":"Radiation Therapy and Ammonium Tetrathiomolybdate in Treating Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer","status":"WITHDRAWN","sponsor":"Roswell Park Cancer Institute","startDate":"2007-05","conditions":"Lung Cancer","enrollment":""},{"nctId":"NCT03065218","phase":"PHASE4","title":"99mTc Sestamibi Scans In Thyroglobulin Positive Scan Negative Differentiated Thyroid Cancer (DTC) Patients","status":"TERMINATED","sponsor":"Medstar Health Research Institute","startDate":"2016-10","conditions":"Thyroid Cancer","enrollment":4},{"nctId":"NCT02749045","phase":"NA","title":"Simultaneous Assessment of FFR and SPECT","status":"TERMINATED","sponsor":"Prem Soman","startDate":"2016-07","conditions":"Coronary Artery Disease","enrollment":27},{"nctId":"NCT01347710","phase":"PHASE3","title":"A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.","status":"COMPLETED","sponsor":"Lantheus Medical Imaging","startDate":"2011-06","conditions":"Coronary Artery Disease","enrollment":795},{"nctId":"NCT03082456","phase":"NA","title":"Molecular Breast Imaging in Screening Breast Cancer","status":"COMPLETED","sponsor":"Chang Gung Memorial Hospital","startDate":"2015-06-01","conditions":"Breast Cancer","enrollment":164},{"nctId":"NCT00162032","phase":"PHASE3","title":"A Study to Evaluate the Use and Safety of CARDIOLITE® in Pediatric Patients With Kawasaki Disease","status":"COMPLETED","sponsor":"Lantheus Medical Imaging","startDate":"2005-08","conditions":"Kawasaki Disease","enrollment":445},{"nctId":"NCT03555487","phase":"PHASE3","title":"Clinical Value of 18F-FCH PET in Localizing Parathyroid Lesions: Comparison With MIBI Scan.","status":"COMPLETED","sponsor":"National Taiwan University Hospital","startDate":"2015-05-05","conditions":"Parathyroid Diseases","enrollment":103},{"nctId":"NCT01653964","phase":"NA","title":"Evaluation of Half-Dose Molecular Breast Imaging With Wide Beam Reconstruction Processing","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2012-07","conditions":"Breast Cancer","enrollment":83},{"nctId":"NCT01545622","phase":"","title":"Surgeon Compared to Nuclear Radiology Readers for Tc-99m Sestamibi Scans for Parathyroid Disease","status":"COMPLETED","sponsor":"University of Arkansas","startDate":"2008-03","conditions":"Parathyroid Disease","enrollment":61},{"nctId":"NCT01944215","phase":"PHASE1","title":"Evaluation of the Effect of Fasting and Exercise on Uptake of Tc-99m Sestamibi in Breast Tissue","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2013-09","conditions":"Molecular Imaging","enrollment":154},{"nctId":"NCT02869126","phase":"NA","title":"Stress and Rest Myocardial Tomoscintigraphies Using Mono- or Double-isotope Protocol With a Semiconductor Camera","status":"COMPLETED","sponsor":"Central Hospital, Nancy, France","startDate":"2012-09","conditions":"Myocardial Perfusion","enrollment":118},{"nctId":"NCT01434641","phase":"NA","title":"Rapid Stress/Rest Single-Day Tc-99m Sestamibi Myocardial Single Photon Emission Computed Tomography","status":"COMPLETED","sponsor":"St. Luke's-Roosevelt Hospital Center","startDate":"2011-07","conditions":"Coronary Artery Disease","enrollment":102},{"nctId":"NCT01499654","phase":"NA","title":"Half-Dose Radiopharmaceutical in Wide Beam Reconstruction","status":"TERMINATED","sponsor":"Edwin Wu","startDate":"2011-10","conditions":"Myocardial Infarction, Ischemic Heart Disease","enrollment":64},{"nctId":"NCT01019486","phase":"PHASE4","title":"Regadenoson Blood Flow in Type 1 Diabetes (RABIT1D)","status":"COMPLETED","sponsor":"University of Colorado, Denver","startDate":"2009-11","conditions":"Coronary Artery Disease, Type 1 Diabetes Mellitus","enrollment":26},{"nctId":"NCT00705458","phase":"NA","title":"Study Comparing CT Scan and Stress Test in Diagnosing Coronary Artery Disease in Patients Hospitalized for Chest Pain","status":"COMPLETED","sponsor":"Montefiore Medical Center","startDate":"2008-07","conditions":"Coronary Artery Disease, Angina Pectoris, Unstable Angina","enrollment":400},{"nctId":"NCT02024074","phase":"PHASE1","title":"Evaluation of Magnetic Resonance Imaging (MRI) vs Molecular Breast Imaging (Tc-MBI) in Breast Cancer Patients","status":"TERMINATED","sponsor":"Emory University","startDate":"2013-11","conditions":"Breast Cancer","enrollment":1},{"nctId":"NCT01387152","phase":"","title":"Prognosis of Very Low Dose SPECT","status":"COMPLETED","sponsor":"Columbia University","startDate":"2011-11","conditions":"Chest Pain","enrollment":100},{"nctId":"NCT02013726","phase":"NA","title":"MBI and Breast Tomosynthesis Screening Accuracies in Patients With Dense Breast Tissue","status":"WITHDRAWN","sponsor":"Gamma Medica, Inc.","startDate":"2015-04","conditions":"Breast Neoplasms","enrollment":""},{"nctId":"NCT01925170","phase":"NA","title":"Low Dose Molecular Breast Imaging as a Screening Tool for Women With Dense Breasts","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2009-04","conditions":"Breast Cancer","enrollment":1638},{"nctId":"NCT00620373","phase":"NA","title":"Molecular Breast Imaging as a Screening Tool for Women With Dense Breasts","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2005-08","conditions":"Breast Cancer","enrollment":969},{"nctId":"NCT01379677","phase":"PHASE3","title":"Rubidium-82 PET and Tc-99m-MIBI SPET: A Head to Head Comparison","status":"COMPLETED","sponsor":"Advanced Accelerator Applications","startDate":"2011-02","conditions":"Coronary Artery Disease","enrollment":135},{"nctId":"NCT01373944","phase":"","title":"Efficiency and Outcomes of Stress-Only Anger and D-SPECT Stress-Only SPECT MPI","status":"COMPLETED","sponsor":"Aspire Foundation","startDate":"2010-05","conditions":"Coronary Artery Disease","enrollment":500},{"nctId":"NCT01027767","phase":"","title":"Effect of Surgery and Radiation Therapy on Tc-99M Sestamibi Uptake Patterns in Molecular Breast Imaging","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2009-05","conditions":"Breast Cancer","enrollment":23},{"nctId":"NCT00069160","phase":"PHASE2","title":"Tariquidar and Docetaxel to Treat Patients With Lung, Ovarian, Renal and Cervical Cancer","status":"COMPLETED","sponsor":"National Cancer Institute (NCI)","startDate":"2003-09","conditions":"Lung Neoplasms, Ovarian Neoplasms, Cervix Neoplasms","enrollment":48},{"nctId":"NCT00972205","phase":"NA","title":"Paclitaxel and CBT-1(Registered Trademark) to Treat Solid Tumors","status":"COMPLETED","sponsor":"National Cancer Institute (NCI)","startDate":"2007-12","conditions":"Cervical, Ovarian, Lung","enrollment":12},{"nctId":"NCT01368939","phase":"","title":"Investigation of High Resolution Nuclear Breast Imaging Camera (MBI) in Patients Administered Tc-99m Sestamibi (ROSE)","status":"UNKNOWN","sponsor":"Hamilton Health Sciences Corporation","startDate":"2012-03","conditions":"Breast Lesions","enrollment":150},{"nctId":"NCT00804544","phase":"NA","title":"99mTc-MIBI SPECT/CT in Breast Malignancy","status":"TERMINATED","sponsor":"London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's","startDate":"2008-09","conditions":"Breast Cancer","enrollment":4},{"nctId":"NCT00943527","phase":"","title":"Hormonal Effects on Tc-99m Sestamibi Uptake in the Breast","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2008-01","conditions":"Breast Cancer","enrollment":110},{"nctId":"NCT00162045","phase":"PHASE1, PHASE2","title":"A Trial to Determine Radiation Exposure to Organs and Assess the Safety of CARDIOLITE® in Pediatric Subjects","status":"COMPLETED","sponsor":"Lantheus Medical Imaging","startDate":"2005-01","conditions":"Kawasaki Disease","enrollment":79},{"nctId":"NCT00162331","phase":"PHASE4","title":"CARDIOLITE-413: A Study for Patients Who Had a PCI for an Acute MI","status":"COMPLETED","sponsor":"Lantheus Medical Imaging","startDate":"2005-01","conditions":"Myocardial Infarction","enrollment":74},{"nctId":"NCT00162357","phase":"PHASE4","title":"Post-PCI:Cardiac Imaging in Patients With Diabetes to Detect Coronary Artery Blockages Previously Opened by Angioplasty","status":"COMPLETED","sponsor":"Lantheus Medical Imaging","startDate":"2004-04","conditions":"Diabetes Mellitus, Type 2, Coronary Restenosis","enrollment":106},{"nctId":"NCT00162344","phase":"PHASE4","title":"A Study of Stress Heart Imaging in Patients With Diabetes at Risk for Coronary Disease.","status":"COMPLETED","sponsor":"Lantheus Medical Imaging","startDate":"2003-12","conditions":"Diabetes","enrollment":205},{"nctId":"NCT01047150","phase":"","title":"The Comparison of the Necessity of Repeat Myocardial Perfusion SPECT Studies Between Tc-99m Tetro and Tc-99m Mibi","status":"UNKNOWN","sponsor":"Cardiac Imaging of Augusta","startDate":"2010-01","conditions":"Myocardial Ischemia","enrollment":250},{"nctId":"NCT00769275","phase":"","title":"Detection of Ischemia in Asymptomatic Diabetics","status":"COMPLETED","sponsor":"Yale University","startDate":"2000-08","conditions":"Type 2 Diabetes Mellitus","enrollment":1123}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[{"date":"20090428","type":"ORIG","sponsor":"CARDINAL HEALTH 414","applicationNumber":"ANDA078809"},{"date":"20160110","type":"SUPPL","sponsor":"CARDINAL HEALTH 414","applicationNumber":"ANDA078809"},{"date":"19960926","type":"SUPPL","sponsor":"SHINE","applicationNumber":"NDA019785"},{"date":"19970523","type":"SUPPL","sponsor":"SHINE","applicationNumber":"NDA019785"},{"date":"19951214","type":"SUPPL","sponsor":"SHINE","applicationNumber":"NDA019785"},{"date":"19920909","type":"SUPPL","sponsor":"SHINE","applicationNumber":"NDA019785"},{"date":"20080430","type":"SUPPL","sponsor":"SHINE","applicationNumber":"NDA019785"},{"date":"19901221","type":"ORIG","sponsor":"SHINE","applicationNumber":"NDA019785"},{"date":"20191204","type":"SUPPL","sponsor":"SHINE","applicationNumber":"NDA019785"},{"date":"20000211","type":"SUPPL","sponsor":"SHINE","applicationNumber":"NDA019785"},{"date":"20020122","type":"SUPPL","sponsor":"SHINE","applicationNumber":"NDA019785"},{"date":"19970808","type":"SUPPL","sponsor":"SHINE","applicationNumber":"NDA019785"},{"date":"19970424","type":"SUPPL","sponsor":"SHINE","applicationNumber":"NDA019785"},{"date":"19961108","type":"SUPPL","sponsor":"SHINE","applicationNumber":"NDA019785"},{"date":"19951214","type":"SUPPL","sponsor":"SHINE","applicationNumber":"NDA019785"},{"date":"19960228","type":"SUPPL","sponsor":"SHINE","applicationNumber":"NDA019785"},{"date":"19920130","type":"SUPPL","sponsor":"SHINE","applicationNumber":"NDA019785"},{"date":"20000608","type":"SUPPL","sponsor":"SHINE","applicationNumber":"NDA019785"},{"date":"20000114","type":"SUPPL","sponsor":"SHINE","applicationNumber":"NDA019785"},{"date":"19980610","type":"SUPPL","sponsor":"SHINE","applicationNumber":"NDA019785"}],"publicationCount":8,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Technetium Tc99m Sestamibi","genericName":"Technetium Tc99m Sestamibi","companyName":"Lantheus Medical Imaging","companyId":"lantheus-medical-imaging","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Technetium Tc-99m sestamibi is a radiopharmaceutical that accumulates in mitochondria of viable myocardial cells, allowing visualization of myocardial perfusion and viability via nuclear imaging. Used for Myocardial perfusion imaging to assess coronary artery disease and ischemia, Evaluation of myocardial viability in patients with coronary artery disease, Risk stratification in patients with known or suspected coronary artery disease.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}